Autopsy report · NCT03895658

Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)

“PI leaving NIH.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

National Institute of Mental Health (NIMH)

Sponsor type

US National Institutes of Health

Conditions

Unipolar Depression

Interventions

MRI; MagPro TMS stimulator and coil; Thymatron (R) System IV paired with 4X1 HDECT

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
  “PI left NIH.” (93% match in meaning)
• Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
  “Departure of PI” (81% match in meaning)
• Brain Autoregulation Research Study
  “PI departure” (76% match in meaning)
• Immersive VR Environments to Induce and Evaluate Cognitive Fatigability
  “PI left the NIH. Study will not continue.” (76% match in meaning)
• Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement
  “PI resigned.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.